XML 74 R54.htm IDEA: XBRL DOCUMENT v3.22.2.2
Shareholders' Equity - Non-Vested Restricted Stock Units Activity (Details)
6 Months Ended
Jul. 30, 2022
$ / shares
shares
Market Based Restricted Stock Units  
Summary of changes in Company's non-vested restricted stock during period [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period | shares 57,800
Granted, shares | shares 0
Vested, shares | shares 0
Forfeited, shares | shares 0
Expired, shares | shares (12,500)
Non-vested restricted stock shares outstanding at end of period | shares 45,300
Summary of changes in Company's non-vested restricted stock during period, weighted average grant date fair value [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period, weighted average grant date fair value per share | $ / shares $ 3.47
Granted, weighted average grant date fair value per share | $ / shares 0
Vested, weighted average grant date fair value per share | $ / shares 0
Forfeited, weighted average grant date fair value per share | $ / shares 0
Expired, weighted average grant date fair value per share | $ / shares 5.07
Non-vested restricted stock shares outstanding at end of period, weighted average grant date fair value per share | $ / shares $ 3.02
Restricted Stock Units Time Based  
Summary of changes in Company's non-vested restricted stock during period [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period | shares 1,031,300
Granted, shares | shares 975,600
Vested, shares | shares (450,500)
Forfeited, shares | shares (67,100)
Non-vested restricted stock shares outstanding at end of period | shares 1,489,300
Summary of changes in Company's non-vested restricted stock during period, weighted average grant date fair value [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period, weighted average grant date fair value per share | $ / shares $ 7.46
Granted, weighted average grant date fair value per share | $ / shares 3.74
Vested, weighted average grant date fair value per share | $ / shares 6.67
Forfeited, weighted average grant date fair value per share | $ / shares 5.26
Non-vested restricted stock shares outstanding at end of period, weighted average grant date fair value per share | $ / shares $ 5.36
Performance Based Units  
Summary of changes in Company's non-vested restricted stock during period [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period | shares 222,900
Granted, shares | shares 36,400
Non-vested restricted stock shares outstanding at end of period | shares 259,300
Summary of changes in Company's non-vested restricted stock during period, weighted average grant date fair value [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period, weighted average grant date fair value per share | $ / shares $ 4.13
Granted, weighted average grant date fair value per share | $ / shares 1.69
Non-vested restricted stock shares outstanding at end of period, weighted average grant date fair value per share | $ / shares $ 3.79
Restricted Stock Units (RSUs)  
Summary of changes in Company's non-vested restricted stock during period [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period | shares 1,312,000
Granted, shares | shares 1,012,000
Vested, shares | shares (450,500)
Forfeited, shares | shares (67,100)
Expired, shares | shares (12,500)
Non-vested restricted stock shares outstanding at end of period | shares 1,793,900
Summary of changes in Company's non-vested restricted stock during period, weighted average grant date fair value [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period, weighted average grant date fair value per share | $ / shares $ 6.72
Granted, weighted average grant date fair value per share | $ / shares 3.67
Vested, weighted average grant date fair value per share | $ / shares 6.67
Forfeited, weighted average grant date fair value per share | $ / shares 5.26
Expired, weighted average grant date fair value per share | $ / shares 5.07
Non-vested restricted stock shares outstanding at end of period, weighted average grant date fair value per share | $ / shares $ 5.07